ZABDENO
Live / Allowed — Fifth extension granted (statement of use) (as of 07 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Dec 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97706853
- Mark type
- Word mark
- Filed
- 07 Dec 2022
- Published for opposition
- 26 Sept 2023
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 07 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Aug 2026 — SOU EXTENSION 5 GRANTED
- 20 Apr 2026 — SOU EXTENSION 5 FILED
- 07 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Oct 2025 — SOU EXTENSION 4 GRANTED
- 07 Oct 2025 — SOU EXTENSION 4 FILED
- 07 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 02 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2025 — SOU EXTENSION 3 GRANTED
- 01 May 2025 — SOU EXTENSION 3 FILED
- 01 May 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Oct 2024 — SOU EXTENSION 2 GRANTED